On a side note, didn't MNTA do some minor trials for mLovenox, which we never heard about until after approval?
They did do some clinical immunogenicity trails. These trials as I recall are the basis for the SNY lawsuit against the FDA stating that the j pathway doesn't allow for trials showing safety/efficacy. The FDA counters that the immunogenicity trials were for assessing manufacturing purity.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.